823-90-5 Usage
Uses
Used in Pharmaceutical and Agrochemical Synthesis:
2(1H)-Pyrimidinone, 5-chloro-, hydrazone (9CI) is used as a building block for the synthesis of various pharmaceuticals and agrochemicals. Its unique structure and functional groups make it a valuable component in the development of new drugs and pesticides.
Used in Biological Research:
2(1H)-Pyrimidinone, 5-chloro-, hydrazone (9CI) is used as a research tool in biological studies, particularly for its potential anti-inflammatory and antitumor properties. Its ability to modulate biological pathways and exhibit therapeutic effects makes it a promising candidate for further investigation in the field of medicine.
Used in Material Science:
2(1H)-Pyrimidinone, 5-chloro-, hydrazone (9CI) is utilized in the development of new materials due to its chemical properties. Its hydrazone functionality allows for the creation of novel compounds with unique characteristics, contributing to advancements in material science.
Used in Organic Synthesis:
As a reagent in organic synthesis, 2(1H)-Pyrimidinone, 5-chloro-, hydrazone (9CI) is employed to facilitate various chemical reactions. Its versatility in forming different types of bonds and its reactivity make it a valuable asset in the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 823-90-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 8,2 and 3 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 823-90:
(5*8)+(4*2)+(3*3)+(2*9)+(1*0)=75
75 % 10 = 5
So 823-90-5 is a valid CAS Registry Number.
823-90-5Relevant academic research and scientific papers
Discovery of KDM5A inhibitors: Homology modeling, virtual screening and structure-activity relationship analysis
Wu, Xiaoai,Fang, Zhen,Yang, Bo,Zhong, Lei,Yang, Qiuyuan,Zhang, Chunhui,Huang, Shenzhen,Xiang, Rong,Suzuki, Takayoshi,Li, Lin-Li,Yang, Sheng-Yong
supporting information, p. 2284 - 2288 (2016/04/20)
Herein we report the discovery of a series of new KDM5A inhibitors. A three-dimensional (3D) structure model of KDM5A jumonji domain was firstly established based on homology modeling. Molecular docking-based virtual screening was then performed against c
